miRNA-765 may modify MDR by controlling the expression of BATF2 which provided the possibility of an effective therapeutic target against GC [17] the upregulated miR-106b in cancer-associated fibroblasts of GC patients can accelerate the invasion by regulating phosphatase and tensin homolog deleted on chromosome 10 [18]. Here, BATF2 is linked to gastric cancer.